 NEW YORK, Sept. 2, 2021 PRNewswire -- MindMed NASDAQ: MNMD NEO: MMED DE: MMQ the Company, a leading biotech company developing psychedelic-inspired therapies, and BioXcel Therapeutics, Inc. BioXcel, a leading clinical-stage biopharmaceutical company, announce the publication of BioXcels International Patent Application No. 